| scholarly article | Q13442814 |
| P2093 | author name string | Yasuhiro Shimada | |
| Takashi Yao | |||
| Chihaya Kakinuma | |||
| Akira Inomata | |||
| Takefumi Hara | |||
| Keiko Makita-Suzuki | |||
| P2860 | cites work | Agents that induce pseudo-allergic reaction | Q22305370 |
| Liposomes as nanomedical devices | Q28088315 | ||
| Canine hepatic vein branches associated with subendothelial mast cells and an adventitial lymphatic plexus | Q33259020 | ||
| Efficacy and toxicity of paclitaxel (Taxol) for the treatment of canine malignant tumors | Q33360237 | ||
| Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses | Q33417234 | ||
| Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity | Q36248358 | ||
| Intravenous infusion of high doses of liposomes containing NSC 251635, a water-insoluble cytostatic agent. A pilot study with pharmacokinetic data | Q36474990 | ||
| Electron microscope observations on compounds 48-80-induced degranulation in rat mast cells. Evidence for sequential exocytosis of storage granules | Q36503120 | ||
| The role of histamine in allergic diseases | Q36603353 | ||
| Liposomal daunorubicin as treatment for Kaposi's sarcoma | Q37004096 | ||
| Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia | Q37080458 | ||
| Liposome triggering of innate immune responses: a perspective on benefits and adverse reactions. | Q37514348 | ||
| Regulatory mechanisms in lymphatic vessel contraction under normal and inflammatory conditions | Q37640880 | ||
| Doxil®--the first FDA-approved nano-drug: lessons learned | Q38000876 | ||
| A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines | Q38028321 | ||
| Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial | Q41090587 | ||
| Characterization of hemodynamic, hematologic, and biochemical responses to administration of liposome-encapsulated hemoglobin in the conscious, freely moving rat. | Q42495485 | ||
| Elevation of alanine transaminase and gallbladder wall abnormalities as biomarkers of anaphylaxis in canine hypersensitivity patients | Q43217422 | ||
| Safety Evaluation of Lipid Nanoparticle-Formulated Modified mRNA in the Sprague-Dawley Rat and Cynomolgus Monkey | Q46250879 | ||
| Complement activation-related cardiac anaphylaxis in pigs: role of C5a anaphylatoxin and adenosine in liposome-induced abnormalities in ECG and heart function | Q46743944 | ||
| Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes | Q57779762 | ||
| Cardiac safety of liposomal anthracyclines | Q60638399 | ||
| Mast cell-Ito cell pairings found in the Disse's spaces in the liver of the beagle dog | Q69791710 | ||
| Electron microscopy of mast cells in the venous wall of canine liver | Q73327107 | ||
| Mechanism of transient dyspnea induced by pegylated-liposomal doxorubicin (Doxil) | Q74276909 | ||
| Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction | Q74332512 | ||
| Ultrastructural study on the venous sphincter in the sublobular vein of the canine liver | Q74765739 | ||
| CHARACTERISTIC DISTRIBUTION OF MAST CELLS IN DOG LIVER. A CONSIDERATION ON THE MECHANISM OF ANAPHYLACTIC SHOCK | Q76933381 | ||
| Liposomal cisplatin combined with gemcitabine in pretreated advanced pancreatic cancer patients: a phase I-II study | Q83093782 | ||
| Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome | Q84444951 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 1-9 | |
| P577 | publication date | 2019-09-12 | |
| P1433 | published in | Journal of Toxicologic Pathology | Q15724542 |
| P1476 | title | Dog-specific hemorrhagic changes induced by liposomal formulations, in the liver and the gallbladder | |
| P478 | volume | 33 |
Search more.